Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Huang (Plan les ouates, Switzerland), C. Bertinetti (Plan les ouates, Switzerland), O. Verbeke (Plan les ouates, Switzerland), M. Caul-Futy (Plan les ouates, Switzerland), P. Alouani (Plan les ouates, Switzerland), L. Wiszniewski (Plan les ouates, Switzerland), S. Constant (Plan les ouates, Switzerland). Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro. 5455

Member's Comments

No comment yet.

Related content which might interest you: Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Source: Eur Respir J 2003; 21: 401-406 Year: 2003 Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa Source: Eur Respir J 2011; 38: 409-414 Year: 2011 Time-dependent response of airway epithelial cells to Staphylococcus aureus Source: Eur Respir J 2004; 24: Suppl. 48, 555s Year: 2004 Resistance of respiratory tract Streptococcus pneumoniae strains Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Pseudomonas aeruginosa influences the inflammatory response of primary bronchial epithelial cells to rhinovirus infection Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 The antimicrobial molecule elafin protects the lung against Staphylococcus aureus infection Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Biofilm production and adherence to airway epithelial cells of P. aeruginosa strains: effect of N-acetyl-cysteine Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia Source: Eur Respir J 2010; 36: 1337-1345 Year: 2010 Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in vivo Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Klebsiella pneumonae triggers rapid release IL(IL)-26 in human neutrophils Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Pseudomonas aeruginosa and cyanide production Source: Eur Respir J 2011; 37: 482-483 Year: 2011 Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model Source: Eur Respir J 2007; 29: 965-968 Year: 2007